Replies to post #95663 on Biotech Values

[DewDiligence]

ACHN:

…you're not suggesting that the control arm response should lead one to view the ACH-1625 data suspiciously are you?

No, I did not mean to suggest that. The placebo data were curious, but I don’t think they have any consequence for investors.